Non-specific adsorption of complement proteins affects complement activation pathways of gold nanomaterials

References

• Andersen AJ, Robinson JT, Dai H, Hunter AC, Andresen TL, Moghimi SM. 2013a. Single-walled carbon nanotube surface control of complement recognition and activation. ACS Nano 7:1108–19.
   PubMed Web of Science ®Google Scholar
• Andersen AJ, Windschiegl B, Ilbasmis-Tamer S, Degim IT, Hunter AC, Andresen TL, Moghimi SM. 2013b. Complement activation by PEG-functionalized multi-walled carbon nanotubes is independent of PEG molecular mass and surface density. Nanomed Nanotechnol Biol Med 9:469–73.
   PubMed Web of Science ®Google Scholar
• Banda NK, Mehta G, Chao Y, Wang G, Inturi S, Fossati-Jimack L, et al. 2014. Mechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serum. Particle and Fibre Toxicology 11:1.
   PubMed Web of Science ®Google Scholar
• Brouwer N, Frakking FN, Van De Wetering MD, Van Houdt M, Hart M, Budde IK, et al. 2009. Mannose-binding lectin (MBL) substitution: recovery of opsonic function in vivo lags behind MBL serum levels. J Immunol 183:3496–504.
   PubMed Web of Science ®Google Scholar
• Cedzynski M, Atkinson AP, St Swierzko A, Macdonald SL, Szala A, Zeman K, et al. 2009. L-ficolin (ficolin-2) insufficiency is associated with combined allergic and infectious respiratory disease in children. Mol Immunol 47:415–19.
   PubMed Web of Science ®Google Scholar
• Chanda N, Kan P, Watkinson LD, Shukla R, Zambre A, Carmack TL, et al. 2010. Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-198AuNP nanoconstruct in prostate tumor-bearing mice. Nanomedicine 6:201–9.
   PubMed Web of Science ®Google Scholar
• Chithrani BD, Ghazani AA, Chan WC. 2006. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6:662–8.
   PubMed Web of Science ®Google Scholar
• Cole LE, Ross RD, Tilley JM, Vargo-Gogola T, Roeder RK. 2015. Gold nanoparticles as contrast agents in x-ray imaging and computed tomography. Nanomedicine (Lond) 10:321–41.
   PubMed Web of Science ®Google Scholar
• Deng ZJ, Liang M, Monteiro M, Toth I, Minchin RF. 2011. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat Nanotechnol 6:39–44.
   PubMed Web of Science ®Google Scholar
• Deng ZJ, Liang M, Toth I, Monteiro M, Minchin RF. 2012a. Plasma protein binding of positively and negatively charged polymer-coated gold nanoparticles elicits different biological responses. Nanotoxicology 7:314–22.
   PubMed Web of Science ®Google Scholar
• Deng ZJ, Liang M, Toth I, Monteiro MJ, Minchin RF. 2012b. Molecular interaction of poly(acrylic acid) gold nanoparticles with human fibrinogen. ACS Nano 6:8962–9.
   PubMed Web of Science ®Google Scholar
• Deng ZJ, Mortimer G, Schiller T, Musumeci A, Martin D, Minchin RF. 2009. Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology 20:455101.
   PubMed Web of Science ®Google Scholar
• De Paula PF, Barbosa JE, Junior PR, Ferriani VP, Latorre MR, Nudelman V, Isaac L. 2003. Ontogeny of complement regulatory proteins - concentrations of factor h, factor I, c4b-binding protein, properdin and vitronectin in healthy children of different ages and in adults. Scand J Immunol 58:572–7.
   PubMed Web of Science ®Google Scholar
• Dézsi L, Fülöp T, Mészáros T, Szénási G, Urbanics R, Vázsonyi C, et al. 2014. Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: comparison of the porcine and rat responses. J Control Release 195:2–10.
   PubMed Web of Science ®Google Scholar
• Dillon SP, D’souza A, Kurien BT, Scofield RH. 2009. Systemic lupus erythematosus and C1q: a quantitative ELISA for determining C1q levels in serum. Biotechnol J 4:1210–14.
   PubMedGoogle Scholar
• Dobrovolskaia MA, Neun BW, Man S, Ye X, Hansen M, Patri AK, et al. 2014. Protein corona composition does not accurately predict hematocompatibility of colloidal gold nanoparticles. Nanomedicine 10:1453–63.
   PubMed Web of Science ®Google Scholar
• Dobrovolskaia MA, Patri AK, Zheng J, Clogston JD, Ayub N, Aggarwal P, et al. 2009. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomedicine 5:106–17.
   PubMed Web of Science ®Google Scholar
• Dunkelberger JR, Song WC. 2010. Complement and its role in innate and adaptive immune responses. Cell Res 20:34–50.
   PubMed Web of Science ®Google Scholar
• Eisen DP, Dean MM, Boermeester MA, Fidler KJ, Gordon AC, Kronborg G, et al. 2008. Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection. Clin Infect Dis 47:510–16.
   PubMed Web of Science ®Google Scholar
• Endo Y, Matsushita M, Fujita T. 2015. New insights into the role of ficolins in the lectin pathway of innate immunity. Int Rev Cell Mol Biol 316:49–110.
   PubMedGoogle Scholar
• Endo Y, Takahashi M, Fujita T. 2006. Lectin complement system and pattern recognition. Immunobiology 211:283–93.
   PubMed Web of Science ®Google Scholar
• Falagan-Lotsch P, Grzincic EM, Murphy CJ. 2016. One low-dose exposure of gold nanoparticles induces long-term changes in human cells. Proc Natl Acad Sci USA 113:11318–23.
   PubMed Web of Science ®Google Scholar
• Fallarini S, Paoletti T, Battaglini CO, Ronchi P, Lay L, Bonomi R, et al. 2013. Factors affecting T cell responses induced by fully synthetic glyco-gold-nanoparticles. Nanoscale 5:390–400.
   PubMed Web of Science ®Google Scholar
• Frakking FN, Brouwer N, Zweers D, Merkus MP, Kuijpers TW, Offringa M, Dolman KM. 2006. High prevalence of mannose-binding lectin (MBL) deficiency in premature neonates. Clin Exp Immunol 145:5–12.
   PubMed Web of Science ®Google Scholar
• Frens G. 1973. Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nature 241:20–2.
   Web of Science ®Google Scholar
• Gad SC, Sharp KL, Montgomery C, Payne JD, Goodrich GP. 2012. Evaluation of the toxicity of intravenous delivery of auroshell particles (gold–silica nanoshells). Int J Toxicol 31:584–94.
   PubMed Web of Science ®Google Scholar
• Gamal-Eldeen AM, Moustafa D, El-Daly SM, El-Hussieny EA, Saleh S, Khoobchandani M, et al. 2016. Photothermal therapy mediated by gum Arabic-conjugated gold nanoparticles suppresses liver preneoplastic lesions in mice. J Photochem Photobiol B 163:47–56.
   PubMed Web of Science ®Google Scholar
• Harris JM, Chess RB. 2003. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2:214–21.
   PubMed Web of Science ®Google Scholar
• He S, Kang MWC, Khan FJ, Tan EKM, Reyes MA, Kah JCY. 2015. Optimizing gold nanostars as a colloid-based surface-enhanced Raman scattering (SERS) substrate. J Opt 17:114013.
   Web of Science ®Google Scholar
• Hu M, Chen J, Li Z-Y, Au L, Hartland GV, Li X, et al. 2006. Gold nanostructures: engineering their plasmonic properties for biomedical applications. Chem Soc Rev 35:1084–94.
   PubMed Web of Science ®Google Scholar
• Huang X, Jain PK, El-Sayed IH, El-Sayed MA. 2007. Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine (Lond) 2:681–93.
   Google Scholar
• Hulander M, Lundgren A, Berglin M, Ohrlander M, Lausmaa J, Elwing H. 2011. Immune complement activation is attenuated by surface nanotopography. Int J Nanomed 6:2653.
   PubMed Web of Science ®Google Scholar
• Inturi S, Wang G, Chen F, Banda NK, Holers VM, Wu L, et al. 2015. Modulatory role of surface coating of superparamagnetic iron oxide nanoworms in complement opsonization and leukocyte uptake. ACS Nano 9:10758–68.
   PubMed Web of Science ®Google Scholar
• Jensen ML, Honoré C, Hummelshøj T, Hansen BE, Madsen HO, Garred P. 2007. Ficolin-2 recognizes DNA and participates in the clearance of dying host cells. Mol Immunol 44:856–65.
   PubMed Web of Science ®Google Scholar
• Kah JCY. 2013. Stability and aggregation assays of nanoparticles in biological media. Methods Mol Biol 1025:119–26.
   PubMedGoogle Scholar
• Kah JCY, Chen J, Zubieta A, Hamad-Schifferli K. 2012. Exploiting the protein corona around gold nanorods for loading and triggered release. ACS Nano 6:6730–40.
   PubMed Web of Science ®Google Scholar
• Kah JCY, Olivo M, Chow TH, Song KS, Koh KZ, Mhaisalkar S, Sheppard CJ. 2009. Control of optical contrast using gold nanoshells for optical coherence tomography imaging of mouse xenograft tumor model in vivo. J Biomed Opt 14:054015.
   Google Scholar
• Kemper C, Atkinson JP, Hourcade DE. 2009. Properdin: emerging roles of a pattern-recognition molecule. Annu Rev Immunol 28:131–55.
   Web of Science ®Google Scholar
• Khan AaC, Szebeni J, Savay S, Liebes L, Rafique N, Alving C, Muggia F. 2003. Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil®). Ann Oncol 14:1430–7.
   PubMed Web of Science ®Google Scholar
• Kingston M, Pfau JC, Gilmer J, Brey R. 2016. Selective inhibitory effects of 50-nm gold nanoparticles on mouse macrophage and spleen cells. J Immunotoxicol 13:198–208.
   PubMed Web of Science ®Google Scholar
• Klapper Y, Hamad OA, Teramura Y, Leneweit G, Nienhaus GU, Ricklin D, et al. 2014. Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesicles. Biomaterials 35:3688–96.
   PubMed Web of Science ®Google Scholar
• Kumar KP, Paul W, Sharma CP. 2011. Green synthesis of gold nanoparticles with Zingiber officinale extract: characterization and blood compatibility. Process Biochem 46:2007–13.
   Web of Science ®Google Scholar
• Lal S, Clare SE, Halas NJ. 2008. Nanoshell-enabled photothermal cancer therapy: impending clinical impact. Acc Chem Res 41:1842–51.
   PubMed Web of Science ®Google Scholar
• Le Y, Lee S, Kon O, Lu J. 1998. Human l‐ficolin: plasma levels, sugar specificity, and assignment of its lectin activity to the fibrinogen‐like (FBG) domain. FEBS Lett 425:367–70.
   PubMed Web of Science ®Google Scholar
• Libutti SK, Paciotti GF, Byrnes AA, Alexander HR, Gannon WE, Walker M, et al. 2010. Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine. Clin Cancer Res 16:6139–49.
   PubMed Web of Science ®Google Scholar
• Libutti SK, Paciotti GF, Myer L, Haynes R, Gannon W, Walker M, et al.2009. Results of a completed phase I clinical trial of CYT-6091: a pegylated colloidal gold-TNF nanomedicine. J Clin Oncol 27:15s (suppl; abstr 3586).
   Google Scholar
• Liu J, Ali MA, Shi Y, Zhao Y, Luo F, Yu J, et al. 2009. Specifically binding of L-ficolin to N-glycans of HCV envelope glycoproteins E1 and E2 leads to complement activation. Cell Mol Immunol 6:235.
   PubMed Web of Science ®Google Scholar
• Luty AJ, Kun JF, Kremsner PG. 1998. Mannose-binding lectin plasma levels and gene polymorphisms in Plasmodium falciparum malaria. J Infect Dis 178:1221–4.
   PubMed Web of Science ®Google Scholar
• Lynch NJ, Roscher S, Hartung T, Morath S, Matsushita M, Maennel DN, et al. 2004. L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of Gram-positive bacteria, and activates the lectin pathway of complement. J Immunol 172:1198–202.
   PubMed Web of Science ®Google Scholar
• Ma YG, Cho MY, Zhao M, Park JW, Matsushita M, Fujita T, Lee BL. 2004. Human mannose-binding lectin and L-ficolin function as specific pattern recognition proteins in the lectin activation pathway of complement. J Biol Chem 279:25307–12.
   PubMed Web of Science ®Google Scholar
• Matsushita M, Endo Y, Fujita T. 2000. Cutting edge: complement-activating complex of ficolin and mannose-binding lectin-associated serine protease. J Immunol 164:2281–4.
   PubMed Web of Science ®Google Scholar
• Merkel OM, Urbanics R, Bedocs P, Rozsnyay Z, Rosivall L, Toth M, et al. 2011. In vitro and in vivo complement activation and related anaphylactic effects associated with polyethylenimine and polyethylenimine-graft-poly(ethylene glycol) block copolymers. Biomaterials 32:4936–42.
   PubMed Web of Science ®Google Scholar
• Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT. 2015. Complement system part I - molecular mechanisms of activation and regulation. Front Immunol 6:262
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Andersen AJ, Ahmadvand D, Wibroe PP, Andresen TL, Hunter AC. 2011. Material properties in complement activation. Adv Drug Deliv Rev 63:1000–7.
   PubMed Web of Science ®Google Scholar
• Molino NM, Bilotkach K, Fraser DA, Ren D, Wang S-W. 2012. Complement activation and cell uptake responses toward polymer-functionalized protein nanocapsules. Biomacromolecules 13:974–81.
   PubMed Web of Science ®Google Scholar
• Nalbant Esenturk E, Hight Walker AR. 2009. Surface-enhanced Raman scattering spectroscopy via gold nanostars. J Raman Spectrosc 40:86–91.
   Web of Science ®Google Scholar
• Nimi N, Paul W, Sharma CP. 2011. Blood protein adsorption and compatibility studies of gold nanoparticles. Gold Bulletin 44:15–20.
   Web of Science ®Google Scholar
• Otsuka H, Nagasaki Y, Kataoka K. 2003. PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev 55:403–19.
   PubMed Web of Science ®Google Scholar
• Paciotti GF, Zhao J, Cao S, Brodie PJ, Tamarkin L, Huhta M, et al. 2016. Synthesis and evaluation of paclitaxel-loaded gold nanoparticles for tumor-targeted drug delivery. Bioconjug Chem 27:2646?57.
   PubMed Web of Science ®Google Scholar
• Pondman KM, Pednekar L, Paudyal B, Tsolaki AG, Kouser L, Khan HA, et al. 2015. Innate immune humoral factors, C1q and factor H, with differential pattern recognition properties, alter macrophage response to carbon nanotubes. Nanomedicine 11:2109–18.
   PubMed Web of Science ®Google Scholar
• Pondman KM, Sobik M, Nayak A, Tsolaki AG, Jakel A, Flahaut E, et al. 2014a. Complement activation by carbon nanotubes and its influence on the phagocytosis and cytokine response by macrophages. Nanomedicine 10:1287–99.
   PubMed Web of Science ®Google Scholar
• Pondman KM, Tsolaki AG, Paudyal B, Shamji MH, Switzer A, Pathan AA, et al. 2016. Complement deposition on nanoparticles can modulate immune responses by macrophage, B and T cells. J Biomed Nanotechnol 12:197–216.
   PubMed Web of Science ®Google Scholar
• Reuveni T, Motiei M, Romman Z, Popovtzer A, Popovtzer R. 2011. Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study. Int J Nanomed 6:2859–64.
   PubMed Web of Science ®Google Scholar
• Ricklin D, Hajishengallis G, Yang K, Lambris JD. 2010. Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11:785–97.
   PubMed Web of Science ®Google Scholar
• Rus H, Cudrici C, Niculescu F. 2005. The role of the complement system in innate immunity. Immunol Res 33:103–12.
   PubMed Web of Science ®Google Scholar
• Saha K, Rahimi M, Yazdani M, Kim ST, Moyano DF, Hou S, et al. 2016. Regulation of macrophage recognition through the interplay of nanoparticle surface functionality and protein corona. ACS Nano 10:4421–30.
   PubMed Web of Science ®Google Scholar
• Salvador-Morales C, Basiuk EV, Basiuk VA, Green ML, Sim RB. 2008. Effects of covalent functionalization on the biocompatibility characteristics of multi-walled carbon nanotubes. J Nanosci Nanotechnol 8:2347–56.
   PubMed Web of Science ®Google Scholar
• Salvador-Morales C, Flahaut E, Sim E, Sloan J, Green ML, Sim RB. 2006. Complement activation and protein adsorption by carbon nanotubes. Mol Immunol 43:193–201.
   PubMed Web of Science ®Google Scholar
• Schafranski MD, Stier A, Nisihara R, Messias-Reason IJ. 2004. Significantly increased levels of mannose-binding lectin (MBL) in rheumatic heart disease: a beneficial role for MBL deficiency. Clin Exp Immunol 138:521–5.
   PubMed Web of Science ®Google Scholar
• Simpson CA, Salleng KJ, Cliffel DE, Feldheim DL. 2013. In vivo toxicity, biodistribution, and clearance of glutathione-coated gold nanoparticles. Nanomedicine 9:257–63.
   PubMed Web of Science ®Google Scholar
• Song H, He C, Knaak C, Guthridge JM, Holers VM, Tomlinson S. 2003. Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation. J Clin Invest 111:1875–85.
   PubMed Web of Science ®Google Scholar
• Szebeni J. 2005. Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity. Toxicology 216:106–21.
   PubMed Web of Science ®Google Scholar
• Szebeni J, Bedőcs P, Rozsnyay Z, Weiszhár Z, Urbanics R, Rosivall L, et al. 2012. Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome. Nanomedicine 8:176–84.
   PubMed Web of Science ®Google Scholar
• Tan Y, Song D, Wu L-H, Yu F, Zhao M-H. 2013. Serum levels and renal deposition of C1q complement component and its antibodies reflect disease activity of lupus nephritis. BMC Nephrol 14:63.
   PubMed Web of Science ®Google Scholar
• Toapanta FR, Ross TM. 2006. Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity. Immunol Res 36:197–210.
   PubMed Web of Science ®Google Scholar
• Tomic S, Ethokic J, Vasilijic S, Ogrinc N, Rudolf R, Pelicon P, et al. 2014. Size-dependent effects of gold nanoparticles uptake on maturation and antitumor functions of human dendritic cells in vitro. PLoS One 9:e96584.
   PubMed Web of Science ®Google Scholar
• Tsai CY, Lu SL, Hu CW, Yeh CS, Lee GB, Lei HY. 2012. Size-dependent attenuation of TLR9 signaling by gold nanoparticles in macrophages. J Immunol 188:68–76.
   PubMed Web of Science ®Google Scholar
• Verhoef JJ, Anchordoquy TJ. 2013. Questioning the use of PEGylation for drug delivery. Drug Deliv Transl Res 3:499–503.
   PubMed Web of Science ®Google Scholar
• Verhoef JJ, Carpenter JF, Anchordoquy TJ, Schellekens H. 2014. Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics. Drug Discov Today 19:1945–52.
   PubMed Web of Science ®Google Scholar
• Veronese FM, Pasut G. 2005. PEGylation, successful approach to drug delivery. Drug Discov Today 10:1451–8.
   PubMed Web of Science ®Google Scholar
• Wang H, Zheng L, Peng C, Shen M, Shi X, Zhang G. 2013a. Folic acid-modified dendrimer-entrapped gold nanoparticles as nanoprobes for targeted CT imaging of human lung adencarcinoma. Biomaterials 34:470–80.
   PubMed Web of Science ®Google Scholar
• Wang S, Huang P, Nie L, Xing R, Liu D, Wang Z, et al. 2013b. Single continuous wave laser induced photodynamic/plasmonic photothermal therapy using photosensitizer-functionalized gold nanostars. Adv Mater 25:3055–61.
   PubMed Web of Science ®Google Scholar
• Yang Q, Lai SK. 2015. Anti‐PEG immunity: emergence, characteristics, and unaddressed questions. Wiley Interdiscipl Rev 7:655–77.
   Google Scholar
• Yen HJ, Hsu SH, Tsai CL. 2009. Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes. Small 5:1553–61.
   PubMed Web of Science ®Google Scholar
• Yeo ELL, Cheah JUJ, Neo DJH, Goh WI, Kanchanawong P, Soo KC, et al. 2017. Exploiting the protein corona around gold nanorods for low-dose combined photothermal and photodynamic therapy. J Mater Chem B 5:254–68.
   PubMed Web of Science ®Google Scholar
• Yeo ELL, Chua AJS, Parthasarathy K, Yeo HY, Ng ML, Kah JCY. 2015. Understanding aggregation-based assays: nature of protein corona and number of epitopes on antigen matters. RSC Adv 5:14982–93.
   Web of Science ®Google Scholar
• You J, Zhou J, Zhou M, Liu Y, Robertson JD, Liang D, et al. 2014. Pharmacokinetics, clearance, and biosafety of polyethylene glycol-coated hollow gold nanospheres. Particle Fibre Toxicol 11:1.
   PubMed Web of Science ®Google Scholar
• Yu K, Lai BF, Foley JH, Krisinger MJ, Conway EM, Kizhakkedathu JN. 2014. Modulation of complement activation and amplification on nanoparticle surfaces by glycopolymer conformation and chemistry. ACS Nano 8:7687–703.
   PubMed Web of Science ®Google Scholar